ROP
53
-9
HRB
59
2
V
64
-2
JNPR
50
-6
ORLY
60
-5
O
17
-13
NOV
52
-5
SO
57
6
MLM
45
-5
WAT
48
-11
GILD
47
-8
BBY
52
6
FSLR
44
-2
ACN
47
-5
CAT
59
-2
CSCO
58
-2
WU
24
4
DLTR
38
-4
PCAR
56
-5
GM
74
5
ROP
53
-9
HRB
59
2
V
64
-2
JNPR
50
-6
ORLY
60
-5
O
17
-13
NOV
52
-5
SO
57
6
MLM
45
-5
WAT
48
-11
GILD
47
-8
BBY
52
6
FSLR
44
-2
ACN
47
-5
CAT
59
-2
CSCO
58
-2
WU
24
4
DLTR
38
-4
PCAR
56
-5
GM
74
5
Financhill
Back

DuPont de Nemours Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
53

DD
DuPont de Nemours

Last Price:
81.83
Seasonality Move:
2.13%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
53
DuPont de Nemours (DD) is a Buy

Is DuPont de Nemours a Buy, Sell or Hold?

  • The current DuPont de Nemours [DD] share price is $81.85. The Score for DD is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • DD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DD Stock Price Chart

What is DuPont de Nemours's stock price today?

  • The DuPont de Nemours share price today is $81.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DD is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

DD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.47 Sell
Relative Strength Index (14 RSI): 42.16 Sell
Chaikin Money Flow: -1501799 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (82.75 - 85.49) Sell
Bollinger Bands (100): (79.4 - 85.18) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

DD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 83.67 Sell
20-day SMA: 83.73 Sell
50-day SMA: 84.31 Sell
200-day SMA: 78.57 Buy
8-day EMA: 83.18 Sell
20-day EMA: 83.78 Sell
50-day EMA: 83.72 Sell
200-day EMA: 79.78 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

DuPont de Nemours Earnings Growth & DD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.44 per share, and an increase next year of $0.50 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

DuPont de Nemours Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):